Valneva (VALN)

Valneva (VALN) Stock Price & Analysis


VALN Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$9.07 - $17.05
Previous Close$11.29
Average Volume (3M)7.03K
Market Cap
Enterprise Value$643.34M
Total Cash (Recent Filing)$289.43M
Total Debt (Recent Filing)$152.38M
Price to Earnings (P/E)N/A
Mar 21, 2024
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
Shares Outstanding69,183,741
10 Day Avg. Volume3,222
30 Day Avg. Volume7,034
Standard Deviation0.27
Financial Highlights & Ratios
Price to Book (P/B)4.00
Price to Sales (P/S)6.81
Price to Cash Flow (P/CF)-3.40
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue2.57
Enterprise Value/Gross Profit-2.81
Enterprise Value/Ebitda-7.70
Price Target Upside136.36% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1



Ownership Overview

0.03% Mutual Funds
0.56% Other Institutional Investors
99.41% Public Companies and
Individual Investors


What was Valneva’s price range in the past 12 months?
Valneva lowest stock price was $9.07 and its highest was $17.05 in the past 12 months.
    What is Valneva’s market cap?
    Currently, no data Available
    When is Valneva’s upcoming earnings report date?
    Valneva’s upcoming earnings report date is Mar 21, 2024 which is in 104 days.
      How were Valneva’s earnings last quarter?
      Valneva released its earnings results on Nov 09, 2023. The company reported -$0.27 earnings per share for the quarter, beating the consensus estimate of -$0.304 by $0.034.
        Is Valneva overvalued?
        According to Wall Street analysts Valneva’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Valneva pay dividends?
          Valneva does not currently pay dividends.
          What is Valneva’s EPS estimate?
          Valneva’s EPS estimate is $0.65.
            How many shares outstanding does Valneva have?
            Valneva has 69,448,300 shares outstanding.
              What happened to Valneva’s price movement after its last earnings report?
              Valneva reported an EPS of -$0.27 in its last earnings report, beating expectations of -$0.304. Following the earnings report the stock price went up 6.672%.
                Which hedge fund is a major shareholder of Valneva?
                Currently, no hedge funds are holding shares in VALN


                Company Description


                Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes two vaccines for travellers; one for the prevention of Japanese encephalitis (IXIARO) and the second (DUKORAL) for the prevention of cholera and diarrhoea. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, and third-party products; Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; and Technologies and services which relates to services and inventions at a commercialization stage. The group is based in France and operates internationally.


                Forecast EPS vs Actual EPS

                Similar Stocks
                Price & Change
                Inovio Pharmaceuticals

                Popular Stocks

                What's Included in PREMIUM?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis